Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

Author: Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Publisher: Springer Publishing Company

ISSN: 0939-5555

Source: Annals of Hematology, Vol.86, Iss.2, 2007-02, pp. : 107-115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content